Dewpoint Therapeutics Funding: $287M Raised, Series C (2022)
Dewpoint Therapeutics is a Biotech company based in Boston, MA. It has raised $287M in total funding. Latest round: Series C.
Dewpoint Therapeutics funding overview
Dewpoint Therapeutics is a Biotech company based in Boston, MA. Dewpoint Therapeutics has raised $287M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in February 2022. The round record for Dewpoint Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include SoftBank Vision Fund 2, General Catalyst, Mubadala Capital, 3E Bioventures Capital, Mirae Asset Capital, NS Investment and 6 others. 12 distinct backers are named across the disclosed rounds.
Dewpoint Therapeutics at a glance
Total raised
$287M
Latest round
Series C
Latest round date
February 2022
Industry
Biotech
Headquarters
Boston, MA
Notable investors
SoftBank Vision Fund 2, General Catalyst, Mubadala Capital, 3E Bioventures Capital, Mirae Asset Capital, NS Investment, Leaps by Bayer, Polaris Partners
Frequently asked about Dewpoint Therapeutics funding
How much has Dewpoint Therapeutics raised?
Dewpoint Therapeutics has raised $287M in total disclosed funding across the rounds on record.
Who has invested in Dewpoint Therapeutics?
SoftBank Vision Fund 2, General Catalyst, Mubadala Capital, 3E Bioventures Capital, Mirae Asset Capital, NS Investment are named among the investors backing Dewpoint Therapeutics.
What was the latest Dewpoint Therapeutics funding round?
The most recent disclosed round is a Series C, announced in February 2022.
Where is Dewpoint Therapeutics based?
Dewpoint Therapeutics is based in Boston, MA.
What sector does Dewpoint Therapeutics operate in?
Dewpoint Therapeutics is tracked under Biotech from Boston, MA, with $287M in disclosed funding.
When did Dewpoint Therapeutics last raise?
The last disclosed Dewpoint Therapeutics round closed in February 2022 at Series C.
Dewpoint Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Boston below to benchmark round size and investor mix.
